Blue Bird Corp Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Blue Bird Corporation on April 6, 2023, covering events occurring on March 31, 2023, and April 1, 2023. The Company is incorporated in Delaware and trades on the NASDAQ Global Market under the symbol BLBD.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statement data.
Material Changes
- Director Resignation: Mr. Chan Galbato, a Class II director, tendered his resignation effective April 3, 2023. The resignation was not based on any disagreement with the Company regarding operations, policies, or practices.
- Director Election: The Board elected Mr. Simon J. Newman as a Class II director on March 31, 2023, to fill the vacancy created by the recent resignation of Dr. Kathleen Shaw.
Management Commentary and Risks
Mr. Newman brings over 40 years of manufacturing industry experience, including roles as Chairman of MW Components and Paragon Medical, and former CEO of Form Technologies. He has not been appointed to any Board committees at this time. There are no arrangements or understandings between Mr. Newman and other persons regarding his election, and no transactions requiring disclosure under Item 404(a) of Regulation S-K. He will participate in director compensation programs consistent with other directors.
Key Facts for Investor Verification
- Confirm the effective date of Mr. Galbato's resignation (April 3, 2023).
- Verify Mr. Newman's background and current board affiliations (MW Components, Paragon Medical, Elgen Manufacturing, Chromalloy).
- Note that no financial performance data is included in this specific filing.
- Review the attached press release (Exhibit 99.1) for additional context on these governance changes.